Comparison of the effects of analgesia and complications of subcutaneous and intravenous ketamine in closed reduction of nasal fracture

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191011045060N1

Enrollment

Registered

2020-01-26

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal fracture. Fracture of nasal bones, initial encounter for closed fracture

Interventions

Intervention 1: Intervention group 1: Intervention group 1:. The first group of patients receiving subcutaneous ketamine (0.5 mg / kg) who will be injected into the anterior forearm. Intervention 2: I

Eligibility

Sex/Gender

All

Age

5 Years to 60 Years

Inclusion criteria

Inclusion criteria: Ages 5 to 60 years Patients with nasal fractures

Exclusion criteria

Exclusion criteria: Drug sensitivity or anesthesia Pregnancy History of seizures History of hypertension comoncold History of brain trauma

Design outcomes

Primary

Measure	Time frame
Pain scale. Timepoint: When you enter the recovery ward, then 15 and 30 minutes later. Method of measurement: The pain will be measured on a VAS scale. In this model, pain scores of 0 and the most pain a patient can imagine are recorded with a score of 10.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVadood norouzi

Ardabil University of Medical Sciences

meisamfooladi@gmail.com+98 45 3323 0739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026